Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Monitoring of the treatment response in eosinophilic oesophagitis (EoE) requires structured endoscopical and histological examination of the oesophagus. Less invasive methods would be highly desirable.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Aliment. Pharmacol. Ther.

Title: Alimentary pharmacology & therapeutics

ISSN (Electronic): 1365-2036

ISSN (Print): 0269-2813

Publication date (Electronic): Nov 2015

Volume: 42

Issue: 9

Affiliations

[1 ] 2nd Medical Department, Technische Universität München, Munich, Germany.

[2 ] Center for Digestive Diseases Eppendorf, Hamburg, Germany.

[3 ] Institute for Immunology, Ludwig-Maximillian-Universität München, Munich, Germany.

[4 ] Department of Dermatology and Allergy Biederstein, Technische Universität München, Munich, Germany.

[5 ] Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany.

[6 ] Swiss EoE Research Network, Olten, Switzerland.

[7 ] Institute for Pathology, Klinikum Bayreuth, Bayreuth, Germany.

[8 ] Institute for Pathology, Kantonsspital Luzern, Luzern, Switzerland.

[9 ] Dr Falk Pharma GmbH, Freiburg, Germany.

Article

DOI: 10.1111/apt.13386

PubMed ID: 26314389

SO-VID: b62dfed2-7608-4121-9c99-a4062cf32889

History

Data availability:

Comments

Comment on this article

scite_

Cited by 23

See all cited by